✦ LIBER ✦
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients
✍ Scribed by Marino Clavio; Luana Vignolo; Alessandra Albarello; Riccardo Varaldo; Ivana Pierri; Gioacchino Catania; Manuela Balocco; Gianluca Michelis; Maurizio Miglino; Annunziata Manna; Enrico Balleari; A. Michele Carella; Mario Sessarego; Maria Teresa Van Lint; Andrea Bacigalupo; Marco Gobbi
- Book ID
- 108675275
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 560 KB
- Volume
- 138
- Category
- Article
- ISSN
- 0007-1048
No coin nor oath required. For personal study only.